Table 5.
Cannabis-Related Variables, Sample Sizes Used for Hypothesis Tests, and Descriptive Statisticse | Expected Medium-to-Large Effect Size | Expected Small-to-Medium Effect Size | ||||
---|---|---|---|---|---|---|
RETROSUB a | Brief DAST b | SCIDc Cannabis Use Disorder | Number of Past Incarcerations | NEO-FFI d Neuroticism | NEO-FFI d Conscientiousness | |
Age at onset of daily cannabis use (16.8±2.8) | N/A | N/A |
t=1.83 p=.080 (d=.731) n=27 |
ρ=−.022 p=.911 n=29 |
ρ=−.462 p=.018 n=26 |
ρ=.219 p=.283 n=26 |
Lifetime cannabis dose (5,141±13,225) | ρ=.486 p=.001 n=43 |
ρ=.551 p<.001 n=50 |
U=153.0 p<.001 (θ=.210) n=54 |
ρ=.597 p<.001 n=58 |
ρ=.199 p=.167 n=50 |
ρ=−.176 p=.223 n=50 |
Cannabis-related problem behaviors (4.5±6.1) | N/A | ρ=.681 p<.001 n=54 |
U=209.0 p=.017 (θ=.310) n=52 |
ρ=.428 p=.001 n=56 |
ρ=.157 p=.285 n=48 |
ρ=−.241 p=.099 n=48 |
Past 12-week cannabis dose (105±227) | ρ=.634 p<.001 n=45 |
N/A | N/A | N/A | ρ=.109 p=.445 n=51 |
ρ=−.015 p=.917 n=51 |
Retrospective Use of Alcohol and Other Substances
The Drug Abuse Screening Test, Brief Version
Structured Clinical Interview for DSM-IV Axis I Disorders
Neuroticism, Extraversion, Openness Five-Factor Inventory
Mean and standard deviation